News

Filter

Current filters:

Vaccines

226 to 235 of 97574 results

FDA sees no need for advisory panel meeting over Pfizer’s Ibrance

09-01-2015

US pharma giant Pfizer says it has been advised by the Food and Drug Administration that at this time…

IbranceOncologypalbociclibPfizerPharmaceuticalRegulationUSA

GW and Otsuka report Sativex failed to meet primary endpoint in cancer pain

GW and Otsuka report Sativex failed to meet primary endpoint in cancer pain

09-01-2015

UK-based GW Pharmaceuticals and Japanese drugmaker Otsuka have reported that Sativex (nabiximols) did…

AnalgesiaGW PharmaceuticalsOncologyOtsuka PharmaceuticalPharmaceuticalResearchSativexUKUSA

Biogen Idec reports positive results from Phase II trial of anti-LINGO-1 in acute optic neuritis

Biogen Idec reports positive results from Phase II trial of anti-LINGO-1 in acute optic neuritis

09-01-2015

US biotech firm Biogen Idec has announced positive top-line results from its Phase II trial of anti-LINGO-1…

anti-LINGO-1Biogen IdecBiotechnologyOphthalmicsResearchUSA

Favorable investment climate and health care reforms will fuel Turkey’s life sciences industry; report

09-01-2015

Big pharmaceutical companies and foreign investors are flocking to Turkey to capitalize on its encouraging…

Markets & MarketingPharmaceuticalPricingRegulationTurkey

FDA approves Daiichi Sankyo’s anti-clotting drug Savaysa

09-01-2015

The US Food and Drug Administration late yesterday approved Japanese drug major Daiichi Sankyo’s anti-clotting…

Cardio-vascularDaiichi SankyoedoxabanPharmaceuticalRegulationSavaysaUSA

FDA Focus: Recalling dangerous and defective drugs

FDA Focus: Recalling dangerous and defective drugs

08-01-2015

In a monthly FDA-focused blog published exclusively by The Pharma Letter, Dr Nicola Davies looks at how…

DrugsPharmaceuticalRegulationUnited StatesUSA

226 to 235 of 97574 results

Back to top